| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate |
2006-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f22544ec1cfd67684f9ee1f7aadcb870
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_192b203563abe67a9ed84666994268df |
| publicationDate |
2008-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080052663-A |
| titleOfInvention |
EBL2 variants and their use in the prevention or treatment of thromboembolic disorders and coronary heart disease |
| abstract |
The present invention relates to human EGLN2 variants having serine or leucine at position 58 of the amino acid sequence, and to thromboembolic disorders or coronary heart disease, in particular stroke, delayed reversible ischemic nerve defect (PRIND), transient ischemic attack (TIA), myocardial infarction And / or use thereof in the prevention or treatment of premature myocardial infarction. |
| priorityDate |
2005-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |